Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Sort By: Relevancy | Date | Type
Displaying items 13-24 of 116
» View wsbtradio.com items only
    Apr 30, 2013 |Story| Reuters
  1. Court stops EU regulator releasing drug company data

    Reuters
    By Ben Hirschler LONDON, April 30 (Reuters) - Europe's medicines regulator has been stopped from releasing clinical trial data about drugs made by AbbVie and Intermune, following a court ruling favouring the two U.S. companies. The European Medicines...

    Tags: European Union, Trials, Litigation, Humira (drug), Drugs and Medicines

  2. Apr 26, 2013 |Story| Chicago Tribune
  3. Humira sales propel AbbVie in 1Q

    In its first quarter as an independent, publicly traded company, AbbVie Inc. said net income rose 9.6 percent, to $968 million, or 60 cents a share, from $883 million, or 56 cents a share, a year earlier when the company was still a part of Abbott Laboratories.
    Tribune staff reporter
    In its first quarter as an independent, publicly traded company, AbbVie Inc. said net income rose 9.6 percent, to $968 million, or 60 cents a share, from $883 million, or 56 cents a share, a year earlier when the company was still a part of Abbott...

    Tags: Abbott Laboratories, Psoriasis, Corporate Officers, Humira (drug), Crohn's Disease

  4. Apr 26, 2013 |Story| Reuters
  5. AbbVie meets expectations, fueled by Humira sales

    Reuters
    April 26 (Reuters) - AbbVie Inc reported slightly better than expected quarterly results, fueled by surging sales of its Humira treatment for rheumatoid arthritis. The pharmaceuticals business, spun off by Abbott Laboratories at the beginning of the...

    Tags: Humira (drug), Thomson Corporation, Drugs and Medicines

  6. Apr 25, 2013 |Story| Reuters
  7. Bristol-Myers Squibb sales disappoint, shares fall

    Reuters
    (Reuters) - Bristol-Myers Squibb reported disappointing first-quarter sales, prompting a drop in shares that have risen sharply this year on enthusiasm for its lineup of promising experimental drugs. The company on Thursday said sales plunged 27...

    Tags: Cardiac Arrhythmia, Liver Cancer, Edward Jones, Plavix (drug), High Blood Pressure

  8. Apr 25, 2013 |Story| Reuters
  9. Pfizer's new arthritis drug rejected by European regulators

    Reuters
    April 25 (Reuters) - European regulators, citing the risks of the drug compared with its potential benefit, declined to approve marketing of Pfizer Inc's new rheumatoid arthritis treatment Xeljanz, the company said on Thursday. Pfizer said it plans to...

    Tags: Diseases and Illnesses, Symptoms, Arthritis

  10. Apr 24, 2013 |Story| Chicago Tribune
  11. Can stem cells help those with arthritis?

    Stems cells taken from just a few grams of body fat are a promising weapon against the crippling effects of osteoarthritis.
    Stems cells taken from just a few grams of body fat are a promising weapon against the crippling effects of osteoarthritis. For the past two decades, knee, hip or other joint replacements have been the standard treatment for the deterioration of joint...

    Tags: Research, Medical Research, Arthritis

  12. Apr 24, 2013 |Story| Los Angeles Times
  13. Amgen stock drops 7% as revenue misses Wall St. forecasts

    Shares of biotech giant Amgen Inc. slumped as investors reacted to weaker-than-expected first-quarter sales.
    Shares of biotech giant Amgen Inc. slumped as investors reacted to weaker-than-expected first-quarter sales. Shares of the Thousand Oaks company dropped $7.83, or 7%, to $104.93 in trading Wednesday. The company's stock had posted impressive gains until...

    Tags: Enbrel (drug), Amgen Inc.

  14. Apr 24, 2013 |Story| Los Angeles Times
  15. Shares of biotech giant Amgen slide on disappointing sales

    Shares of biotech giant Amgen Inc. slumped Wednesday as investors reacted to weaker-than-expected first-quarter sales.
    Shares of biotech giant Amgen Inc. slumped Wednesday as investors reacted to weaker-than-expected first-quarter sales. Shares of the Thousand Oaks company dropped $6.41, or nearly 6%, to $106.35 in trading Wednesday. The company's stock had posted...

    Tags: Enbrel (drug), Amgen Inc.

  16. Apr 23, 2013 |Story| Reuters
  17. Amgen first-quarter profit, revenue rise

    Reuters
    April 23 (Reuters) - Amgen Inc on Tuesday reported higher first-quarter profit on increased sales of its drug Enbrel for rheumatoid arthritis and newer medicines to help prevent bone fractures. The world's largest biotechnology company posted a net...

    Tags: Chemical Industry, Biotechnology Industry, Science and Technology, Enbrel (drug), Thomson Corporation

  18. Apr 18, 2013 |Column| South Florida Sun-Sentinel
  19. Best diet for people with autoimmune disease

    Dear Pharmacist: Your post on rheumatoid arthritis and autoimmune disease intrigued me. I didn't realize eating beans, peanuts, peas, lentils, soy or tofu was an issue. I eat these foods frequently, and I still hurt. Can you tell me more? —D.B.,...

    Tags: Hyperthyroidism, Chemical Industry, Lupus, Lentils, Diseases and Illnesses

  20. Apr 10, 2013 |Column| South Florida Sun-Sentinel
  21. A natural script to help relieve chronic pain

    <strong>Dear Pharmacist: I live in chronic pain. No one is sure why. I take hydrocodone and ibuprofen daily, but I'm still in pain. Can you recommend any vitamins to help me? &mdash; M.C., Dallas, Texas</strong>
    Dear Pharmacist: I live in chronic pain. No one is sure why. I take hydrocodone and ibuprofen daily, but I'm still in pain. Can you recommend any vitamins to help me? — M.C., Dallas, Texas Dear M.C.: I'm sorry you are going through this. Luckily,...

    Tags: Hydrocodone (drug), Psoriasis, Herbal Supplements, Heart Failure, Pain

  22. Mar 6, 2013 |Story| Reuters
  23. Too much salt may trigger autoimmune diseases: studies

    Reuters
    CHICAGO (Reuters) - Increased salt consumption may be a key culprit behind rising rates of autoimmune diseases such as multiple sclerosis, researchers reported on Wednesday in a trio of papers looking at the role of a specific class of cells linked with...

    Tags: Psoriasis, Diets and Dieting, Science and Technology, Genetic Engineering, High Blood Pressure

< Previous1  2  3 4 5 6 7 8 9 10Next >
Original site for Rheumatoid Arthritis topic gallery.
Loading...
 
 

Date:

Credit:

User-submitted

Tags:

Rate:
Sending...

E-mail this photo

Error: malformed email address(es)
Both "from" and "recipient" email fields are required.

Recipient E-mail Addresses

(up to 3, separated by commas) Send me a copy.

From:

e-mail | buy this photo | link to photo
Rheumatoid Arthritis Photos
He began his career with four years in medical educatio...
(December 18, 2012)
Mark Finn, vice president, AbelsonTaylor
***McGee has enjoyed a successful career as a dancer an...
(October 19, 2012)
Jamile McGee
Barbara Seigfreid, 27, has been promoted to account exe...
(September 20, 2012)
Barbara Seigfreid, account executive, AbelsonTaylor